All respiratory syncytial virus articles
-
NewsStudy in Europe: monoclonal antibodies effectively prevent respiratory syncytial virus in infants
Data from Belgium, Portugal and Spain show that immunisation of children after birth reduced the risk of hospitalization due to RSV infection by almost 80%.
-
NewsHow does infection with respiratory syncytial virus affect the health of older adults?
Adults aged 65 and older hospitalized for RSV in Ontario experienced significantly higher rates of adverse outcomes such as longer length of hospital stay, transfer to intensive care, and 30-day mortality, compared with patients hospitalized with influenza, urinary tract infection, or fracture.
-
NewsResearchers use biophysics to design new vaccines against RSV and related respiratory viruses
Scientists improved existing vaccines by analyzing the molecular structure and stability of viral proteins.
-
NewsResearchers identify signs tied to more severe cases of RSV
In a new study, researchers found an increase in NK cells in the airways of children with severe RSV as well as other alterations that suggest these cells may be contributing to disease severity.